HFE gene mutations in coronary atherothrombotic disease.

Although iron can catalyze the production of free radicals involved in LDL lipid peroxidation, the contribution of iron overload to atherosclerosis remains controversial. The description of two mutations in the HFE gene (Cys282Tyr and His63Asp) related to hereditary hemochromatosis provides an opportunity to address the question of the association between iron overload and atherosclerosis. We investigated the prevalence of HFE mutations in 160 survivors of myocardial infarction with angiographically demonstrated severe coronary atherosclerotic disease, and in 160 age-, gender- and race-matched healthy control subjects. PCR amplification of genomic DNA followed by RsaI and BclI restriction enzyme digestion was used to determine the genotypes. The frequency of the mutant Cys282Tyr allele was identical among patients and controls (0.022; carrier frequency, 4.4%), whereas the mutant His63Asp allele had a frequency of 0.143 (carrier frequency, 27.5%) in controls and of 0.134 (carrier frequency, 24.5%) in patients. Compound heterozygotes were found in 2 of 160 (1.2%) controls and in 1 of 160 (0.6%) patients. The finding of a similar prevalence of Cys282Tyr and His63Asp mutations in the HFE gene among controls and patients with coronary atherothrombotic disease, indirectly questions the possibility of an association between hereditary hemochromatosis and atherosclerosis.

[1]  J. McCord Iron, free radicals, and oxidative injury. , 2004, Seminars in hematology.

[2]  R. Hegele,et al.  Polymorphism in intron 4 of HFE may cause overestimation of C282Y homozygote prevalence in haemochromatosis , 1999, Nature Genetics.

[3]  Trip,et al.  Prevalence of hereditary haemochromatosis in premature atherosclerotic vascular disease , 1998, British journal of haematology.

[4]  Gillum Rf Body iron stores and atherosclerosis. , 1997 .

[5]  StefanKiechl,et al.  Body Iron Stores and the Risk of Carotid Atherosclerosis , 1997 .

[6]  W. Poewe,et al.  Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. , 1997, Circulation.

[7]  J. Keaney,et al.  Effect of iron overload and iron deficiency on atherosclerosis in the hypercholesterolemic rabbit. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[8]  J. Keaney,et al.  Antioxidants and atherosclerotic heart disease. , 1997, The New England journal of medicine.

[9]  R. Baumgartner,et al.  Impact of HLA-H mutations on iron stores in healthy elderly men and women. , 1997, Blood cells, molecules & diseases.

[10]  Jennifer J. Pointon,et al.  Global prevalence of putative haemochromatosis mutations. , 1997, Journal of medical genetics.

[11]  D. Meyers The iron hypothesis—Does iron cause atherosclerosis? , 1996, Clinical cardiology.

[12]  M. C. Ellis,et al.  A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis , 1996, Nature Genetics.

[13]  C. Venditti,et al.  Mutation analysis in hereditary hemochromatosis. , 1996, Blood cells, molecules & diseases.

[14]  A. Reunanen,et al.  Body iron stores, dietary iron intake and coronary heart disease mortality , 1995, Journal of internal medicine.

[15]  J. Araujo,et al.  Iron overload augments the development of atherosclerotic lesions in rabbits. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[16]  J. Salonen,et al.  Body iron stores and the risk of coronary heart disease. , 1994, The New England journal of medicine.

[17]  W. Willett,et al.  Are body iron stores related to the risk of coronary heart disease? , 1994, The New England journal of medicine.

[18]  H. Morrison,et al.  Serum iron and risk of fatal acute myocardial infarction. , 1994, Epidemiology.

[19]  M. Burt,et al.  Iron and coronary heart disease. , 1993, BMJ.

[20]  H. Macdonald High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. , 1993, Circulation.

[21]  Heikki Korpela,et al.  High Stored Iron Levels Are Associated With Excess Risk of Myocardial Infarction in Eastern Finnish Men , 1992, Circulation.

[22]  W. Willett,et al.  A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. , 1992, JAMA.

[23]  J. Manson,et al.  Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. , 1991, The New England journal of medicine.

[24]  R. Lauffer Iron stores and the international variation in mortality from coronary artery disease. , 1991, Medical hypotheses.

[25]  K. Mullis,et al.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. , 1988, Science.

[26]  J. Sullivan IRON AND THE SEX DIFFERENCE IN HEART DISEASE RISK , 1981, The Lancet.

[27]  F. Skrabal RECTAL POTENTIAL DIFFERENCE IN ESSENTIAL HYPERTENSION , 1976, The Lancet.

[28]  B. Woolf ON ESTIMATING THE RELATION BETWEEN BLOOD GROUP AND DISEASE , 1955, Annals of human genetics.

[29]  N. Andrews,et al.  Iron is hot: an update on the pathophysiology of hemochromatosis. , 1998, Blood.

[30]  T. Bothwell,et al.  Hereditary hemochromatosis: etiologic, pathologic, and clinical aspects. , 1998, Seminars in hematology.

[31]  J. George,et al.  Idiopathic thrombocytopenic purpura: A concise summary of the pathophysiology and diagnosis in children and adults. , 1998, Seminars in hematology.

[32]  C. Hennekens,et al.  Iron status and risk of cardiovascular disease. , 1997, Annals of epidemiology.

[33]  J. Jessurun,et al.  Ferritin protects endothelial cells from oxidized low density lipoprotein in vitro. , 1995, The American journal of pathology.